For renal function assessment, median serum creatinine and eGFR change between week 24 and week 0 were +10.5 (Q1 -8.8, Q3 +19.3) mol/L and -7.5 (Q1 -12.3, Q3 -1.3) mL/min/1.73m 2 respectively
Envigo-teklad, Indiana, USA)
Disclosures: Jasmine Ahmed: Nothing to Disclose, Deanna Oliver: Nothing to Disclose, Yaseen Kady: Nothing to Disclose, Julian Diaz-Moreno: Nothing to Disclose, James Johnson: Nothing to Disclose, Eric Storey: Nothing to Disclose, Maryam Yasso: Nothing to Disclose, Anna Hefner: Nothing to Disclose, Tarek Hassanein: Nothing to Disclose 447 INCIDENCE OF HEPATITIS DELTA VIRUS SUPER-INFECTION IN HBSAG POSITIVE PATIENTS FROM FRANCE AND THE GAMBIA (THE INCI-D COHORT STUDY) Patrick INGILIZ 1 Erwan Vo Quang 2 Maud Lemoine 3 Amie Ceesay 4 Gibril Ndow 5 Marie-Noelle Hilleret 6 Laure Bordy 7 Thomas Decaens 6 Anne-Laure Mazialivoua 8 Yusuke Shimakava 9 Alhagie Bakoteh 5 Jean-Michel Pawlotsky 10 Isabelle CHEMIN 4 Stphane Chevaliez 11 Vincent Leroy 8 , 1 APHP Henri-Mondor University Hospital, 2 INSERM U955, Crteil, France, MRC The Gambia Unit@London School of Hygiene and Tropical Medicine, F, 3 Imperial College London, London, UK, 4 Cancer Research Centre, INSERM, Lyon, France, 5 MRC The Gambia Unit@London School of Hygiene and Tropical Medicine, Fajara, The Gambia, 6 University Hospital Grenoble-Alpes, Hepatology Department, Grenoble, France, 7 [email protected], 8 APHP Henri-Mondor University Hospital, Hepatology Department, Crteil, France, 9 Unit d'pidmiologie des Maladies mergentes, Institut Pasteur, Paris, France, 10 INSERM U955, Crteil, France, 11 INSERM U955 Background: Super- infection with the hepatitis D virus (HDV) leads to a more aggressive form of chronic hepatitis in patients infected with the hepatitis B virus (HBV)
Molecular studies show collagen VI deposition initiates cellular responses including enhanced inflammatory mediator production and disrupted insulin signaling networks (97)
Jumping straight to high tirzepatide doses or high retatrutide doses without proper escalation dramatically increases both the severity and duration of GI side effects
